Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Terri B. Hunter
Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Related publications
P3.04-27 an Allogeneic Tumor Cell Lysate Vaccine Induces Immune Responses to Lung Cancer Associated Antigens: Preliminary Results of a Phase II Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase II Trial of Methylglyoxal Bis-Guanylhydrazone (MGBG) in Refractory Small Cell Lung Cancer
Investigational New Drugs
Oncology
Pharmacology
Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models
PLoS ONE
Multidisciplinary
Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Inhaled GM-CSF in a Pulmonary Alveolar Proteinosis Patient Refractory to Plasmapheresis Combined With Multiple Whole Lung Lavages
Archives of Pulmonology and Respiratory Care
Anti-Tumor Activity of CrTX in Human Lung Adenocarcinoma Cell Line A549
Acta Pharmacologica Sinica
Medicine
Pharmacology
Combined Small Cell Lung Carcinoma and Adenocarcinoma With a Neuroendocrine Phenotype
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Anlotinib Combined With S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial
Asian Pacific Journal of Cancer Prevention
A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Cancer Research and Treatment
Cancer Research
Oncology
